Literature DB >> 24926691

Phenotype and genotype analysis in patients with macular corneal dystrophy.

Anna K Nowinska1, Edward Wylegala1, Sławomir Teper1, Ewa Wróblewska-Czajka1, Pasquale Aragona2, Anna M Roszkowska2, Antonio Micali3, Antonina Pisani3, Domenico Puzzolo3.   

Abstract

AIM: The aim of this study was to analyse corneal morphological organisation and identify mutations in the carbohydrate sulfotransferase 6 gene (CHST6) in patients with macular corneal dystrophy originating in a Polish population.
METHODS: Macular corneal dystrophy was diagnosed in 24 patients based on the slit-lamp exam, confocal microscopy, 1310 nm time domain and 840 nm spectral domain optical coherence tomography. 10 corneal buttons obtained from penetrating keratoplasty were processed for light microscopy. Genetic analysis of the CHST6 gene was performed, followed by a study of the sequencing results.
RESULTS: Highly reflective, diffuse corneal deposits and a general increase in reflectivity were revealed with optical coherence tomography and confocal microscopy. The deposits extended from the Bowman layer to the Descemet membrane and correlated with the Alcian blue-positive granular-filamentous material into and around the stromal keratocytes confirmed by structural analysis of the corneal buttons. The genetic analysis of the blood samples identified the following mutations and single nucleotide polymorphisms: novel P64L (heterozygous), Y110C (homozygous), R162G and L200R, and M1L (heterozygous and homozygous).
CONCLUSIONS: Genetic mutation heterogeneity was revealed. No phenotype heterogeneity was revealed among patients with in vivo corneal morphology assessment or histological analysis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Cornea; Dystrophy

Mesh:

Substances:

Year:  2014        PMID: 24926691     DOI: 10.1136/bjophthalmol-2014-305098

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Clinical diversity in macular corneal dystrophy: an optical coherence tomography study.

Authors:  Sunita Chaurasia; Muralidhar Ramappa; Dilip Kumar Mishra
Journal:  Int Ophthalmol       Date:  2019-06-03       Impact factor: 2.031

2.  Corneal Higher Order Aberrations in Granular, Lattice and Macular Corneal Dystrophies.

Authors:  Yukari Yagi-Yaguchi; Takefumi Yamaguchi; Yumi Okuyama; Yoshiyuki Satake; Kazuo Tsubota; Jun Shimazaki
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

3.  Genetic analysis of CHST6 and TGFBI in Turkish patients with corneal dystrophies: Five novel variations in CHST6.

Authors:  Fulya Yaylacioglu Tuncay; Gülsüm Kayman Kurekci; Sezen Guntekin Ergun; Ozge Tugce Pasaoglu; Rustu Fikret Akata; Pervin Rukiye Dincer
Journal:  Mol Vis       Date:  2016-10-26       Impact factor: 2.367

4.  A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy.

Authors:  Jing Zhang; Dan Wu; Yue Li; Yidan Fan; Yiqin Dai; Jianjiang Xu
Journal:  Aging (Albany NY)       Date:  2019-02-04       Impact factor: 5.682

5.  Novel compound heterozygous mutations in the CHST6 gene cause macular corneal dystrophy in a Han Chinese family.

Authors:  Yanxia Huang; Lamei Yuan; Yanna Cao; Renhong Tang; Hongbo Xu; Ziqian Tang; Hao Deng
Journal:  Ann Transl Med       Date:  2021-04

6.  Detailed corneal and genetic characteristics of a pediatric patient with macular corneal dystrophy - case report.

Authors:  Anna Nowińska; Edyta Chlasta-Twardzik; Michał Dembski; Ewa Wróblewska-Czajka; Klaudia Ulfik-Dembska; Edward Wylęgała
Journal:  BMC Ophthalmol       Date:  2021-07-23       Impact factor: 2.209

7.  Comparative Study of Anterior Eye Segment Measurements with Spectral Swept-Source and Time-Domain Optical Coherence Tomography in Eyes with Corneal Dystrophies.

Authors:  Anna K Nowinska; Sławomir J Teper; Dominika A Janiszewska; Anita Lyssek-Boron; Dariusz Dobrowolski; Robert Koprowski; Edward Wylegala
Journal:  Biomed Res Int       Date:  2015-09-17       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.